Onconova Therapeutics Quarterly Earnings. Should You Buy?


Onconova Therapeutics Quarterly Earnings. Should You Buy?: Onconova Therapeutics (NASDAQ: ONTX)  a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for patients with cancer, announces financial results for the twelve months ended December 31, 2020 and provides a business update. Highlights of the fourth quarter of 2020 and recent weeks include: ON 123300, Onconova’s proprietary multi-kinase inhibitor, received clearance from […]

Comments

Popular posts from this blog

CWEB - Many household products contain antimicrobial chemicals banned from soaps by the FDA

Thousands of Amazon Employees Receive Layoff Mails, Jeff Bezos’ Surprise Visit at Meeting Sparks Fear Among Washington Post Staff